Mesa Laboratories is forecast to grow earnings and revenue by 124.8% and 5.5% per annum respectively. EPS is expected to grow by 124.9% per annum. Return on equity is forecast to be 27.2% in 3 years.
Key information
124.8%
Earnings growth rate
124.9%
EPS growth rate
Life Sciences earnings growth
26.4%
Revenue growth rate
5.5%
Future return on equity
27.2%
Analyst coverage
Low
Last updated
11 Nov 2024
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
DB:MLI - Analysts future estimates and past financials data (USD Millions)
Date
Revenue
Earnings
Free Cash Flow
Cash from Op
Avg. No. Analysts
3/31/2027
263
14
43
53
2
3/31/2026
247
10
41
47
4
3/31/2025
235
9
30
36
3
9/30/2024
228
-246
36
40
N/A
6/30/2024
224
-250
41
45
N/A
3/31/2024
216
-254
42
44
N/A
12/31/2023
213
1
41
44
N/A
9/30/2023
214
-1
36
40
N/A
6/30/2023
219
2
36
41
N/A
3/31/2023
219
1
23
28
N/A
12/31/2022
222
-1
20
25
N/A
9/30/2022
223
-4
28
33
N/A
6/30/2022
200
-2
23
27
N/A
3/31/2022
184
2
35
39
N/A
12/31/2021
163
8
39
43
N/A
9/30/2021
143
5
36
38
N/A
6/30/2021
139
4
42
44
N/A
3/31/2021
134
3
35
37
N/A
12/31/2020
130
-2
31
32
N/A
9/30/2020
128
-2
31
32
N/A
6/30/2020
121
-2
27
29
N/A
3/31/2020
118
2
25
27
N/A
12/31/2019
110
5
27
28
N/A
9/30/2019
105
10
27
28
N/A
6/30/2019
104
8
24
25
N/A
3/31/2019
103
7
29
31
N/A
12/31/2018
104
10
28
30
N/A
9/30/2018
101
-2
27
29
N/A
6/30/2018
99
0
N/A
30
N/A
3/31/2018
96
-3
N/A
26
N/A
12/31/2017
94
-4
N/A
17
N/A
9/30/2017
94
11
N/A
14
N/A
6/30/2017
95
11
N/A
7
N/A
3/31/2017
94
11
N/A
17
N/A
12/31/2016
94
12
N/A
14
N/A
9/30/2016
90
11
N/A
9
N/A
6/30/2016
88
10
N/A
18
N/A
3/31/2016
85
11
N/A
17
N/A
12/31/2015
78
9
N/A
15
N/A
9/30/2015
76
9
N/A
16
N/A
6/30/2015
73
10
N/A
13
N/A
3/31/2015
71
10
N/A
11
N/A
12/31/2014
68
11
N/A
9
N/A
9/30/2014
64
10
N/A
11
N/A
6/30/2014
58
9
N/A
10
N/A
3/31/2014
53
9
N/A
12
N/A
12/31/2013
50
8
N/A
12
N/A
Analyst Future Growth Forecasts
Earnings vs Savings Rate: MLI is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (1%).
Earnings vs Market: MLI is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: MLI is expected to become profitable in the next 3 years.
Revenue vs Market: MLI's revenue (5.5% per year) is forecast to grow slower than the German market (5.6% per year).
High Growth Revenue: MLI's revenue (5.5% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: MLI's Return on Equity is forecast to be high in 3 years time (27.2%)